Rich MacAry

Rich Macary has a diverse work experience spanning several industries. Rich is currently serving as the President of Sinaptica Therapeutics, a clinical-stage neurology-focused company that has developed a breakthrough device-based therapeutic treatment for Alzheimer's Disease. Prior to this role, they were a Board Member at iFabric Corp, a TSX listed corporation. Before that, they served as a Director at Clouds, Inc. and held multiple positions at Delos, including Chief Strategy Officer and President of Delos Ventures. Rich also worked as the Vice President of Business Development at Sarepta Therapeutics and had previous experience as a Managing Partner at Corporate Insights Consulting. Additionally, Rich has served as a Corporate Advisor/Consultant at Sarepta Therapeutics and as a Board Member at Folio Dynamix. Earlier in their career, they held a role as VP at Bear Stearns and as a Vice President at Gabriele Hueglin & Cashman, a boutique bond firm. Rich Macary's expertise lies in business strategy, business development, product development, and intellectual property development.

From 1985 to 1989, Rich Macary attended the University of Connecticut. Rich studied Finance during this time.

Links

Previous companies

Delos logo
Sarepta Therapeutics logo

Org chart

Sign up to view 0 direct reports

Get started


Teams

This person is not in any teams